Ophthalmic Devices Market by Product Function [Ophthalmic Surgery Devices (Refractive Error Surgery Devices, Glaucoma Surgery Devices, Cataract Surgery Devices, and Vitreoretinal Surgery Devices), Ophthalmic Diagnostic Devices (Refractors, Corneal Topography Systems, Retinal Ultrasound Systems, Fundus Camera, Ophthalmoscopes, OCT, Perimeters, Slit Lamps, and Tonometers), Vision Care Devices (Contact Lenses and Spectacles)] - Global Opportunities and Forecasts, 2014-2022Ophthalmology is a branch of medical sciences that deals with the structure, function, and various eye diseases. The ophthalmic devices are medical equipment designed for diagnosis, surgical, and vision correction purposes. These devices gain increased importance and adoption due to high prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision related issues.
Increase in prevalence rate of eye related diseases such as glaucoma, cataract, and others, rapid technological advancements, increased focus on customer training and education, growth in initiatives to spread awareness, and high adoption of digital devices worldwide drive the global ophthalmic devices market. Although these factors are expected to boost the growth of the market, lack of awareness and dearth of skilled professionals are expected to restrict the market growth.
The report segments the global ophthalmic devices based on product function into ophthalmic surgical devices, diagnostic devices, and vision care devices. The ophthalmic surgical devices are further categorized into refractive error surgical devices, glaucoma surgical devices, cataract surgical devices, and vitreoretinal surgical devices. The refractive error surgical devices are sub segmented into excimers and femtosecond lasers, and microkeratomes.
The glaucoma surgical devices are sub segmented into implants and stents, glaucoma drainage devices, and glaucoma laser devices. The cataract surgery devices are further divided into intraocular lenses, viscoelastics, and phacoemulsification systems. The vitreoretinal surgical devices are further categorized into vitrectomy machines & vitrectomy packs, photocoagulation lasers, and illumination devices. The global ophthalmic diagnostic devices are further segmented into refractors, corneal topography systems, retinal ultrasound systems, fundus camera, ophthalmoscopes, optical coherence tomography systems, perimeters, slit lamps, and tonometers. The vision care devices are bifurcated into contact lenses and spectacle lenses. The global ophthalmic devices market is segmented on a regional level into North America, Europe, Asia-Pacific, and LAMEA.
The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis of the industry for the period of 2014–2022 to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market helps understand the trending ophthalmic devices products used for surgical, diagnostic, and vision care applications.
Competitive intelligence of the industry highlights the business practices followed by leading players across various regions.
Comprehensive analysis of the market at the regional and country levels is provided to determine the prevailing opportunities across these geographies.
OPHTHALMIC DEVICES MARKET KEY SEGMENTS
By Product function
Ophthalmic Surgical Devices
Refractive Error Surgical Devices
Excimers and Femtosecond Lasers
Glaucoma Surgical Devices
Implants and Stents
Glaucoma Laser Devices
Cataract Surgery Devices
Vitreoretinal Surgical Devices
Vitrectomy Machines & Vitrectomy Packs
Ophthalmic Diagnostic Devices
Corneal Topography Systems
Retinal Ultrasound Systems
Optical Coherence Tomography Systems
Ophthalmic Vision Care Devices
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
1.1. REPORT DESCRIPTION
1.1.1. Key benefits for stakeholders
1.1.2. Key market segments
1.2. RESEARCH METHODOLOGY
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models
CHAPTER 2. EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3. MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
188.8.131.52. Competitive intelligence of companies and their strategies
3.3. MARKET SHARE ANALYSIS, 2015
3.4. TOP PLAYER POSITIONING
3.5. MARKET DYNAMICS
184.108.40.206. Rising prevalence of eye related diseases worldwide
220.127.116.11. Rapid technological advancements in ophthalmology
18.104.22.168. Increasing focus on customer training and education along with awareness
22.214.171.124. High adoption of digital devices worldwide
126.96.36.199. Low awareness about eye related diseases
188.8.131.52. Dearth of skilled professionals
184.108.40.206. Emerging nations - A great opportunity for ophthalmic devices manufacturers
220.127.116.11. Programs and initiatives worldwide to reduce the burden of eye related diseases
3.6. GOVERNMENT REGULATIONS
3.6.2. CE Mark
3.6.3. Pharmaceuticals and Medical Devices Agency and Ministry of Health, Labor, and Welfare (MHLW)
CHAPTER 4. GLOBAL OPTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION
4.1.1. Market size and forecast
4.2. SURGICAL DEVICES
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Refractive error surgical devices
18.104.22.168. Market size and forecast
22.214.171.124. Excimers and femtosecond lasers
126.96.36.199.1. Market size and forecast
188.8.131.52.1. Market size and forecast
4.2.5. Glaucoma surgical devices
184.108.40.206. Market size and forecast
220.127.116.11. Implants and stents
18.104.22.168.1. Market size and forecast
22.214.171.124. Glaucoma drainage devices
126.96.36.199.1. Market size and forecast
188.8.131.52. Glaucoma laser devices
184.108.40.206.1. Market size and forecast
4.2.6. Cataract surgical devices
220.127.116.11. Market size and forecast
18.104.22.168. Intraocular lenses
22.214.171.124.1. Market size and forecast
126.96.36.199.1. Market size and forecast
188.8.131.52. Phacoemulsification systems
184.108.40.206.1. Market size and forecast
4.2.7. Vitreoretinal surgical devices
220.127.116.11. Market size and forecast
18.104.22.168. Vitrectomy machines and vitrectomy packs
22.214.171.124.1. Market size and forecast
126.96.36.199. Photocoagulation lasers
188.8.131.52.1. Market size and forecast
184.108.40.206. Illumination devices
220.127.116.11.1. Market size and forecast
4.3. DIAGNOSTIC DEVICES
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
18.104.22.168. Market size and forecast
22.214.171.124. Market size and forecast
4.3.4. Corneal topography systems
126.96.36.199. Market size and forecast
4.3.5. Retinal ultrasound systems
188.8.131.52. Market size and forecast
4.3.6. Fundus camera
184.108.40.206. Market size and forecast
220.127.116.11. Market size and forecast
4.3.8. Optical coherence tomography systems
18.104.22.168. Market size and forecast
22.214.171.124. Market size and forecast
4.3.10. Slit lamps
126.96.36.199. Market size and forecast
188.8.131.52. Market size and forecast
4.4. VISION CARE DEVICES
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Contact lenses
184.108.40.206. Market size and forecast
4.4.5. Spectacle lenses
220.127.116.11. Market size and forecast
CHAPTER 5. GLOBAL OPHTHALMIC DEVICES MARKET, BY REGION
5.1.1. Market size and forecast
5.2. NORTH AMERICA
5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S. market size and forecast
5.2.5. Canada market size and forecast
5.2.6. Mexico market size and forecast
5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany market size and forecast
5.3.5. France market size and forecast
5.3.6. UK market size and forecast
5.3.7. Italy market size and forecast
5.3.8. Spain market size and forecast
5.3.9. Rest of the Europe market size and forecast
5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan market size and forecast
5.4.5. China market size and forecast
5.4.6. Australia market size and forecast
5.4.7. India market size and forecast
5.4.8. South Korea market size and forecast
5.4.9. Rest of Asia-Pacific market size and forecast
5.5.1. Key market trends
5.5.2. Growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Brazil market size and forecast
5.5.5. Saudi Arabia market size and forecast
5.5.6. South Africa market size and forecast
5.5.7. Rest of LAMEA market size and forecast
CHAPTER 6. COMPANY PROFILES
6.1. ALCON, INC.
6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments
6.2. CARL ZEISS MEDITEC AG
6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves & developments
6.3. ESSILOR INTERNATIONAL S.A.
6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance
6.4. HAAG-STREIT HOLDING AG
6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.5. HOYA CORPORATION
6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments
6.6. JOHNSON & JOHNSON
6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments
6.7. NIDEK CO., LTD.
6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves & developments
6.8. TOPCON CORPORATION
6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves & developments
6.9. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves & developments
6.10. ZIEMER OPHTHALMIC SYSTEMS AG
6.10.1. Company overview
6.10.2. Business performance
6.10.3. Key strategic moves & developments
Ophthalmology is a branch of medical sciences, which deals with structure, function, and various diseases related to the eye. The ophthalmic device based on the product function are majorly categorized into surgical, diagnostic, and vision care devices. The increase in prevalence of eye related diseases such as glaucoma, cataract, refractive errors, AMD, and others drive the global ophthalmic devices market. Increase in prevalence and technological advancements in the devices also fuel the growth of the market.
Increase in prevalence rate of eye related diseases such as glaucoma, cataract, and others, rapid technological advancements, increase in initiatives to spread awareness, and high adoption of digital devices worldwide boost the global ophthalmology devices market. Although these factors are expected to fuel the growth of ophthalmic devices market, elements such as a lack of awareness and dearth of skilled professionals are projected to hamper the growth of the market.
The cataract surgery devices segment accounted for the major share in the ophthalmic surgical devices market, and is expected to continue its dominance throughout the forecast period. This segment is expected to grow at a CAGR of 4.8% during 2016-2022, owing to high prevalence of cataract worldwide.
Key Findings Of Ophthalmic Devices Market
The surgical devices segment is projected to grow at the fastest rate during the forecast period.
North America held a dominant position in the regional landscape in 2015, occupying a share of more than one-third of the total market.
In 2015, the diagnostic segment accounted for a share of one-third of the total ophthalmic devices market.
The contact lenses segment accounted for a share of more than one-third of the global ophthalmic devices market in 2015.
In 2015, North America accounted for nearly one-third of the global market, owing to the high prevalence of various eye diseases in the region. Europe holds the second position in the global ophthalmic devices market.
The major companies profiled in the report includes Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, Johnson & Johnson, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International, Inc., Hoya Corporation, and Ziemer Ophthalmic Systems AG.
- Novartis AG
- Carl Zeiss Meditec AG
- Essilor International S.A.
- HAAG-Streit Holding AG
- Johnson & Johnson
- Nidek Co., Ltd.
- Topcon Corporation
- Valeant Pharmaceuticals International, Inc.
- Ziemer Ophthalmic Systems
- Hoya Corporation
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.